Novel SDHD Gene Mutation (H102R) in a Patient With Metastatic Cervical Paraganglioma Effectively Treated by Peptide Receptor Radionuclide Therapy [PDF]
, 2011 Thorsten D. Poeppel +8 more
openalex +1 more source
177Lu‐Gold Nanohybrids in Radiotherapeutic Approaches Against Cancer
Small Science, Volume 5, Issue 5, May 2025.This article reviews the literature on nanoscale systems incorporating radioactive lutetium‐177 and gold nanoparticles as amplifying units, applied to internal radionuclide therapy against cancer. A presentation of the lutetium radionuclide, the radioenhancing effect of gold nanoparticles, tumor delivery strategies, and the state of the literature on ...
Mathilde Ponchelle +3 more
wiley +1 more source
68Ga-DOTA-NOC PET and Peptide Receptor Radionuclide Therapy in Management of Bilateral Ovarian Metastases from Gastrointestinal Carcinoid [PDF]
, 2012 Sahil Singla +4 more
openalex +1 more source
Diabetes, Obesity and Metabolism, Volume 27, Issue 5, Page 2720-2729, May 2025.Abstract Aims We assessed changes in body composition following tirzepatide treatment in a substudy of participants with obesity or overweight from the SURMOUNT‐1 trial, overall and post hoc in clinically relevant subgroups. Materials and Methods Substudy participants (n = 160 of the 2539 in SURMOUNT‐1) underwent dual‐energy X‐ray absorptiometry (DXA ...
Michelle Look +7 more
wiley +1 more source
A Unique Matched Quadruplet of Terbium Radioisotopes for PET and SPECT and for α- and β−-Radionuclide Therapy: An In Vivo Proof-of-Concept Study with a New Receptor-Targeted Folate Derivative [PDF]
, 2012 Cristina Müller +8 more
openalex +1 more source
Site‐Specific Modification of Native IgGs with Flexible Drug‐Load
ChemBioChem, Volume 26, Issue 8, April 14, 2025.ADC generation from native IgG: using short, positively charged peptides like RAK enables the direct modification of IgG at the glutamine Q295 without the need for engineering. Using azide‐ and thiol‐group containing RAK, the generation of ADCs with different drug‐to‐antibody ratios (DARs) is demonstrated and their properties analyzed in‐vitro and in ...
Jöri E. Wehrmüller +7 more
wiley +1 more source
On the reduction of imaging time-points for dosimetry in radionuclide therapy. [PDF]
EJNMMI PhysGustafsson J, Taprogge J.
europepmc +1 more source
Application of a whole-body pharmacokinetic model for targeted radionuclide therapy to NM404 and FLT [PDF]
, 2012 Joseph Grudzinski +9 more
openalex +1 more source
Repeated Radionuclide therapy in metastatic paraganglioma leading to the highest reported cumulative activity of 131I-MIBG [PDF]
, 2012 Samer Ezziddin +5 more
openalex +1 more source